Becton Dickinson & Co (BDX): Net Income
$1.68B
Year ended 2025-09-30
$942.00M
Trailing 12 months to 2026-06-30
-1.9%
3-year compound annual growth
+13.9%
5-year compound annual growth
+9.2%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $1.68B | -1.6% | 2025-11-25, From 2024-10-01 |
| 2024-09-30 | $1.71B | +14.9% | 2025-11-25, From 2023-10-01 |
| 2023-09-30 | $1.48B | -16.6% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $1.78B | -15.0% | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | $2.09B | +139.4% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $874.00M | -29.1% | 2022-11-22, From 2019-10-01 |
| 2019-09-30 | $1.23B | +296.5% | 2021-11-24, From 2018-10-01 |
| 2018-09-30 | $311.00M | -71.7% | 2020-11-25, From 2017-10-01 |
| 2017-09-30 | $1.10B | +12.7% | 2019-11-27, From 2016-10-01 |
| 2016-09-30 | $976.00M | +40.4% | 2018-11-21, From 2015-10-01 |
| 2015-09-30 | $695.00M | -41.4% | 2017-11-22, From 2014-10-01 |
| 2014-09-30 | $1.19B | -8.4% | 2016-11-23, From 2013-10-01 |
| 2013-09-30 | $1.29B | +10.5% | 2015-11-25, From 2012-10-01 |
| 2012-09-30 | $1.17B | -7.9% | 2014-11-26, From 2011-10-01 |
| 2011-09-30 | $1.27B | -3.5% | 2013-11-27, From 2010-10-01 |
| 2010-09-30 | $1.32B | +7.0% | 2012-11-21, From 2009-10-01 |
| 2009-09-30 | $1.23B | +9.3% | 2010-01-21, From 2008-10-01 |
| 2008-09-30 | $1.13B | +26.6% | 2010-01-21, From 2007-10-01 |
| 2007-09-30 | $890.03M | n/a | 2010-01-21, From 2006-10-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $1.68B | -1.6% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $2.89B | +56.7% |
| 3M Co (MMM) | 2025-12-31 | $3.25B | -22.1% |
| Stryker Corp (SYK) | 2025-12-31 | $3.25B | +8.5% |
| Medline Inc. (MDLN) | 2025-12-31 | $1.16B | n/a |
| Baxter International Inc (BAX) | 2025-12-31 | -$957.00M | n/m |
| Solventum Corp (SOLV) | 2025-12-31 | $1.56B | +224.8% |
| ResMed Inc (RMD) | 2026-06-30 | $1.52B | +8.8% |
| Dexcom Inc (DXCM) | 2025-12-31 | $836.30M | +45.1% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗